Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|February 22, 2020
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid LeukemiaCiera L Patzke, Alison P Duffy, Vu H Duong, et al.
Frontiers in Oncology|January 10, 2022
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic TargetNoa G Holtzman, Michael S Lebowitz, Rima Koka, et al.
Leukemia & Lymphoma|October 23, 2013
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Vu H Duong, Theodore S Gourdin, et al.
BMC Medicine|January 17, 2015
Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort StudyArash Etemadi, Farin Kamangar, Farhad Islami, et al.
Experimental Hematology|February 1, 2022
Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclaxBandish Kapadia, Amol C Shetty, Dominique Bollino, et al.
Journal of Hematopathology|October 9, 2018
High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenZeba N Singh, Vu H Duong, Rima Koka, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2016
Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cellsBrandon A Carter-Cooper, Steven Fletcher, Dana Ferraris, et al.
Leukemia Research Reports|November 10, 2022
Therapy-related B-lymphoblastic leukemia after multiple myelomaMichael E Kallen, Rima Koka, Zeba N Singh, et al.
Cancer & Metabolism|July 2, 2024
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinomaDominique Bollino, Kanwal Hameed, Anusha Bhat, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|February 22, 2020
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid LeukemiaCiera L Patzke, Alison P Duffy, Vu H Duong, et al.
Frontiers in Oncology|January 10, 2022
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic TargetNoa G Holtzman, Michael S Lebowitz, Rima Koka, et al.
Leukemia & Lymphoma|October 23, 2013
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Vu H Duong, Theodore S Gourdin, et al.
BMC Medicine|January 17, 2015
Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort StudyArash Etemadi, Farin Kamangar, Farhad Islami, et al.
Experimental Hematology|February 1, 2022
Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclaxBandish Kapadia, Amol C Shetty, Dominique Bollino, et al.
Journal of Hematopathology|October 9, 2018
High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenZeba N Singh, Vu H Duong, Rima Koka, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2016
Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cellsBrandon A Carter-Cooper, Steven Fletcher, Dana Ferraris, et al.
Leukemia Research Reports|November 10, 2022
Therapy-related B-lymphoblastic leukemia after multiple myelomaMichael E Kallen, Rima Koka, Zeba N Singh, et al.
Cancer & Metabolism|July 2, 2024
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinomaDominique Bollino, Kanwal Hameed, Anusha Bhat, et al.
Pageof 12